ANXA7 and prostate cancer: Our present high throughput TMA study extended our understanding of the role of ANXA7 towards prostate cancer patients’ survival and established its bimodal function as a tumor apoptotic marker (with optimal level) and tumor proliferative marker (with extremely low or high concentrations).